Immuno-Oncology Webinar: Immunotherapy Cancer Combinations – When, Who and at What Price?
This article was originally published in Scrip
Immuno-oncology may be seen as the future of cancer therapy, but it is combination therapy that is the future of immuno-oncology. The potential to use different types of these novel immune-acting products together to boost cancer control is as exciting in its potential as it is mind-boggling in its complexity. In this third Immuno-Oncology Webinar in Informa's series, our team of experts use exclusive data and insight to delve into the world of combination cancer immunotherapies.
Register for our free email digests: